The global market for Insulin Injection Equipment was valued at US$ 21030 million in the year 2024 and is projected to reach a revised size of US$ 43780 million by 2031, growing at a CAGR of 11.2% during the forecast period.
Insulin injection equipment refers to the medical devices and supplies used by individuals with diabetes to administer insulin into their bodies. Insulin is a hormone that regulates blood sugar levels, and people with diabetes, particularly those with type 1 diabetes and some with type 2 diabetes, require regular insulin injections to manage their condition. Insulin injection equipment includes various components designed to safely and effectively deliver insulin as prescribed by a healthcare professional.
Smart insulin pens are equipped with Bluetooth connectivity and companion smartphone apps. They allow users to track insulin doses, monitor blood glucose levels, and receive reminders for injections. These pens can provide valuable insights into insulin management.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Insulin Injection Equipment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insulin Injection Equipment.
The Insulin Injection Equipment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Insulin Injection Equipment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Insulin Injection Equipment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Becton
Dickinson and Company (BD)
Eli Lilly
Novo Nordisk
Roche
Insulet Corporation
Medtronic
Tandem Diabetes Care
Ypsomed
Valeritas
Sanofi
Animas
Beta Bionics
Cellnovo
Copernicus
Dance Biopharm
Insulet
MannKind
Owen Mumford
SOOIL
West Pharma
Segment by Type
Insulin Pen
Insulin Needle
Insulin Syringe
Others
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Insulin Injection Equipment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Insulin Injection Equipment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Insulin Injection Equipment 麻豆原创 Overview
1.1 Product Definition
1.2 Insulin Injection Equipment by Type
1.2.1 Global Insulin Injection Equipment 麻豆原创 Value Comparison by Type (2024 VS 2031)
1.2.2 Insulin Pen
1.2.3 Insulin Needle
1.2.4 Insulin Syringe
1.2.5 Others
1.3 Insulin Injection Equipment by Application
1.3.1 Global Insulin Injection Equipment 麻豆原创 Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Insulin Injection Equipment 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Insulin Injection Equipment Revenue 2020-2031
1.4.2 Global Insulin Injection Equipment Sales 2020-2031
1.4.3 Global Insulin Injection Equipment 麻豆原创 Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Insulin Injection Equipment 麻豆原创 Competition by Manufacturers
2.1 Global Insulin Injection Equipment Sales 麻豆原创 Share by Manufacturers (2020-2025)
2.2 Global Insulin Injection Equipment Revenue 麻豆原创 Share by Manufacturers (2020-2025)
2.3 Global Insulin Injection Equipment Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Insulin Injection Equipment, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Insulin Injection Equipment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Insulin Injection Equipment, Product Type & Application
2.7 Global Key Manufacturers of Insulin Injection Equipment, Date of Enter into This Industry
2.8 Global Insulin Injection Equipment 麻豆原创 Competitive Situation and Trends
2.8.1 Global Insulin Injection Equipment 麻豆原创 Concentration Rate
2.8.2 The Global 5 and 10 Largest Insulin Injection Equipment Players 麻豆原创 Share by Revenue
2.8.3 Global Insulin Injection Equipment 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Insulin Injection Equipment 麻豆原创 Scenario by Region
3.1 Global Insulin Injection Equipment 麻豆原创 Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Insulin Injection Equipment Sales by Region: 2020-2031
3.2.1 Global Insulin Injection Equipment Sales by Region: 2020-2025
3.2.2 Global Insulin Injection Equipment Sales by Region: 2026-2031
3.3 Global Insulin Injection Equipment Revenue by Region: 2020-2031
3.3.1 Global Insulin Injection Equipment Revenue by Region: 2020-2025
3.3.2 Global Insulin Injection Equipment Revenue by Region: 2026-2031
3.4 North America Insulin Injection Equipment 麻豆原创 Facts & Figures by Country
3.4.1 North America Insulin Injection Equipment 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Insulin Injection Equipment Sales by Country (2020-2031)
3.4.3 North America Insulin Injection Equipment Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Insulin Injection Equipment 麻豆原创 Facts & Figures by Country
3.5.1 Europe Insulin Injection Equipment 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Insulin Injection Equipment Sales by Country (2020-2031)
3.5.3 Europe Insulin Injection Equipment Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Insulin Injection Equipment 麻豆原创 Facts & Figures by Region
3.6.1 Asia Pacific Insulin Injection Equipment 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Insulin Injection Equipment Sales by Region (2020-2031)
3.6.3 Asia Pacific Insulin Injection Equipment Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Insulin Injection Equipment 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Insulin Injection Equipment 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Insulin Injection Equipment Sales by Country (2020-2031)
3.7.3 Latin America Insulin Injection Equipment Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Insulin Injection Equipment 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Insulin Injection Equipment 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Insulin Injection Equipment Sales by Country (2020-2031)
3.8.3 Middle East and Africa Insulin Injection Equipment Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Insulin Injection Equipment Sales by Type (2020-2031)
4.1.1 Global Insulin Injection Equipment Sales by Type (2020-2025)
4.1.2 Global Insulin Injection Equipment Sales by Type (2026-2031)
4.1.3 Global Insulin Injection Equipment Sales 麻豆原创 Share by Type (2020-2031)
4.2 Global Insulin Injection Equipment Revenue by Type (2020-2031)
4.2.1 Global Insulin Injection Equipment Revenue by Type (2020-2025)
4.2.2 Global Insulin Injection Equipment Revenue by Type (2026-2031)
4.2.3 Global Insulin Injection Equipment Revenue 麻豆原创 Share by Type (2020-2031)
4.3 Global Insulin Injection Equipment Price by Type (2020-2031)
5 Segment by Application
5.1 Global Insulin Injection Equipment Sales by Application (2020-2031)
5.1.1 Global Insulin Injection Equipment Sales by Application (2020-2025)
5.1.2 Global Insulin Injection Equipment Sales by Application (2026-2031)
5.1.3 Global Insulin Injection Equipment Sales 麻豆原创 Share by Application (2020-2031)
5.2 Global Insulin Injection Equipment Revenue by Application (2020-2031)
5.2.1 Global Insulin Injection Equipment Revenue by Application (2020-2025)
5.2.2 Global Insulin Injection Equipment Revenue by Application (2026-2031)
5.2.3 Global Insulin Injection Equipment Revenue 麻豆原创 Share by Application (2020-2031)
5.3 Global Insulin Injection Equipment Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Becton
6.1.1 Becton Company Information
6.1.2 Becton Description and Business Overview
6.1.3 Becton Insulin Injection Equipment Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Becton Insulin Injection Equipment Product Portfolio
6.1.5 Becton Recent Developments/Updates
6.2 Dickinson and Company (BD)
6.2.1 Dickinson and Company (BD) Company Information
6.2.2 Dickinson and Company (BD) Description and Business Overview
6.2.3 Dickinson and Company (BD) Insulin Injection Equipment Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Dickinson and Company (BD) Insulin Injection Equipment Product Portfolio
6.2.5 Dickinson and Company (BD) Recent Developments/Updates
6.3 Eli Lilly
6.3.1 Eli Lilly Company Information
6.3.2 Eli Lilly Description and Business Overview
6.3.3 Eli Lilly Insulin Injection Equipment Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Eli Lilly Insulin Injection Equipment Product Portfolio
6.3.5 Eli Lilly Recent Developments/Updates
6.4 Novo Nordisk
6.4.1 Novo Nordisk Company Information
6.4.2 Novo Nordisk Description and Business Overview
6.4.3 Novo Nordisk Insulin Injection Equipment Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Novo Nordisk Insulin Injection Equipment Product Portfolio
6.4.5 Novo Nordisk Recent Developments/Updates
6.5 Roche
6.5.1 Roche Company Information
6.5.2 Roche Description and Business Overview
6.5.3 Roche Insulin Injection Equipment Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Roche Insulin Injection Equipment Product Portfolio
6.5.5 Roche Recent Developments/Updates
6.6 Insulet Corporation
6.6.1 Insulet Corporation Company Information
6.6.2 Insulet Corporation Description and Business Overview
6.6.3 Insulet Corporation Insulin Injection Equipment Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Insulet Corporation Insulin Injection Equipment Product Portfolio
6.6.5 Insulet Corporation Recent Developments/Updates
6.7 Medtronic
6.7.1 Medtronic Company Information
6.7.2 Medtronic Description and Business Overview
6.7.3 Medtronic Insulin Injection Equipment Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Medtronic Insulin Injection Equipment Product Portfolio
6.7.5 Medtronic Recent Developments/Updates
6.8 Tandem Diabetes Care
6.8.1 Tandem Diabetes Care Company Information
6.8.2 Tandem Diabetes Care Description and Business Overview
6.8.3 Tandem Diabetes Care Insulin Injection Equipment Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Tandem Diabetes Care Insulin Injection Equipment Product Portfolio
6.8.5 Tandem Diabetes Care Recent Developments/Updates
6.9 Ypsomed
6.9.1 Ypsomed Company Information
6.9.2 Ypsomed Description and Business Overview
6.9.3 Ypsomed Insulin Injection Equipment Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Ypsomed Insulin Injection Equipment Product Portfolio
6.9.5 Ypsomed Recent Developments/Updates
6.10 Valeritas
6.10.1 Valeritas Company Information
6.10.2 Valeritas Description and Business Overview
6.10.3 Valeritas Insulin Injection Equipment Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Valeritas Insulin Injection Equipment Product Portfolio
6.10.5 Valeritas Recent Developments/Updates
6.11 Sanofi
6.11.1 Sanofi Company Information
6.11.2 Sanofi Description and Business Overview
6.11.3 Sanofi Insulin Injection Equipment Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Sanofi Insulin Injection Equipment Product Portfolio
6.11.5 Sanofi Recent Developments/Updates
6.12 Animas
6.12.1 Animas Company Information
6.12.2 Animas Description and Business Overview
6.12.3 Animas Insulin Injection Equipment Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Animas Insulin Injection Equipment Product Portfolio
6.12.5 Animas Recent Developments/Updates
6.13 Beta Bionics
6.13.1 Beta Bionics Company Information
6.13.2 Beta Bionics Description and Business Overview
6.13.3 Beta Bionics Insulin Injection Equipment Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Beta Bionics Insulin Injection Equipment Product Portfolio
6.13.5 Beta Bionics Recent Developments/Updates
6.14 Cellnovo
6.14.1 Cellnovo Company Information
6.14.2 Cellnovo Description and Business Overview
6.14.3 Cellnovo Insulin Injection Equipment Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Cellnovo Insulin Injection Equipment Product Portfolio
6.14.5 Cellnovo Recent Developments/Updates
6.15 Copernicus
6.15.1 Copernicus Company Information
6.15.2 Copernicus Description and Business Overview
6.15.3 Copernicus Insulin Injection Equipment Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Copernicus Insulin Injection Equipment Product Portfolio
6.15.5 Copernicus Recent Developments/Updates
6.16 Dance Biopharm
6.16.1 Dance Biopharm Company Information
6.16.2 Dance Biopharm Description and Business Overview
6.16.3 Dance Biopharm Insulin Injection Equipment Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Dance Biopharm Insulin Injection Equipment Product Portfolio
6.16.5 Dance Biopharm Recent Developments/Updates
6.17 Insulet
6.17.1 Insulet Company Information
6.17.2 Insulet Description and Business Overview
6.17.3 Insulet Insulin Injection Equipment Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Insulet Insulin Injection Equipment Product Portfolio
6.17.5 Insulet Recent Developments/Updates
6.18 MannKind
6.18.1 MannKind Company Information
6.18.2 MannKind Description and Business Overview
6.18.3 MannKind Insulin Injection Equipment Sales, Revenue and Gross Margin (2020-2025)
6.18.4 MannKind Insulin Injection Equipment Product Portfolio
6.18.5 MannKind Recent Developments/Updates
6.19 Owen Mumford
6.19.1 Owen Mumford Company Information
6.19.2 Owen Mumford Description and Business Overview
6.19.3 Owen Mumford Insulin Injection Equipment Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Owen Mumford Insulin Injection Equipment Product Portfolio
6.19.5 Owen Mumford Recent Developments/Updates
6.20 SOOIL
6.20.1 SOOIL Company Information
6.20.2 SOOIL Description and Business Overview
6.20.3 SOOIL Insulin Injection Equipment Sales, Revenue and Gross Margin (2020-2025)
6.20.4 SOOIL Insulin Injection Equipment Product Portfolio
6.20.5 SOOIL Recent Developments/Updates
6.21 West Pharma
6.21.1 West Pharma Company Information
6.21.2 West Pharma Description and Business Overview
6.21.3 West Pharma Insulin Injection Equipment Sales, Revenue and Gross Margin (2020-2025)
6.21.4 West Pharma Insulin Injection Equipment Product Portfolio
6.21.5 West Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Insulin Injection Equipment Industry Chain Analysis
7.2 Insulin Injection Equipment Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Insulin Injection Equipment Production Mode & Process Analysis
7.4 Insulin Injection Equipment Sales and 麻豆原创ing
7.4.1 Insulin Injection Equipment Sales Channels
7.4.2 Insulin Injection Equipment Distributors
7.5 Insulin Injection Equipment Customer Analysis
8 Insulin Injection Equipment 麻豆原创 Dynamics
8.1 Insulin Injection Equipment Industry Trends
8.2 Insulin Injection Equipment 麻豆原创 Drivers
8.3 Insulin Injection Equipment 麻豆原创 Challenges
8.4 Insulin Injection Equipment 麻豆原创 Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Becton
Dickinson and Company (BD)
Eli Lilly
Novo Nordisk
Roche
Insulet Corporation
Medtronic
Tandem Diabetes Care
Ypsomed
Valeritas
Sanofi
Animas
Beta Bionics
Cellnovo
Copernicus
Dance Biopharm
Insulet
MannKind
Owen Mumford
SOOIL
West Pharma
听
听
*If Applicable.
